Section 4: Clinical Pharmacy Services 2023
DOI: 10.1136/ejhpharm-2023-eahp.119
|View full text |Cite
|
Sign up to set email alerts
|

4CPS-103 Pharmacokinetic interaction study of osimertinib and digoxin: a case report

Abstract: and 'Cause of DRP' (k = 0.594 [95% CI: 0.587 -0.601]). The category 'Planned PI' showed substantial agreement (k = 0.638 [95% CI: 0.629 -0.647]). Test-retest reliability achieved an almost perfect agreement for all three main categories: 'Type of DRP' (k = 0.825 [95% CI: 0.734 -0.915]), 'Cause of DRP' (k = 0.896 [95% CI: 0.825 -0.967]) and 'Planned PI' (k = 0.891 [95% CI: 0.819 -0.964]). The median rater-specific contingency coefficient was 0.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 0 publications
0
0
0
Order By: Relevance